Skip to main content

Advertisement

Log in

Pituitary apoplexy: considerations on a single center experience and review of the literature

  • Short Review
  • Published:
Journal of Endocrinological Investigation Aims and scope Submit manuscript

Abstract

Purpose

To present a single-center experience on pituitary tumor apoplexy and a review of literature focusing on predisposing and precipitating factors.

Methods

Clinical presentation of our series of cases. Contemporary published literature is also reviewed.

Results

The definition of this syndrome has not been consistent although now the majority of authors agree to definite it as an acute condition caused by hemorrhage or infarction of a pre-existing pituitary adenoma. Different predisposing and precipitating factors have been described in literature; among these antithrombotic and anticoagulant drugs, seem to play relevant roles. The clinical cases observed in our clinic confirm these data and suggest a probable association between elderly patients taking anticoagulant therapy and pituitary apoplexy adenoma.

Conclusion

Pituitary tumor apoplexy remains a challenging disease in relation to difficulties in correct diagnosis and thus in appropriate treatment. Antithrombotic/anticoagulant therapy may have an important role as precipitating factor. When a pituitary disorder is known, great care should be taken in the prescription of anticoagulant therapy.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Dubuisson AS, Beckers A, Stevenaert A (2007) Classical pituitary tumour apoplexy: clinical features, management and outcomes in a series of 24 patients. Clin Neurol Neurosurg 109:63–70. doi:10.1016/j.clineuro.2006.01.006

    Article  PubMed  Google Scholar 

  2. Arafah BM, Salti IS (1978) Partial hypopituitarism following septic peritonitis with shock. Arch Intern Med 138:1272–1273

    Article  CAS  PubMed  Google Scholar 

  3. Dash RJ, Gupta V, Suri S (1993) Sheehan’s syndrome: clinical profile, pituitary hormone responses and computed sellar tomography. Aust N Z J Med 23:26–31

    Article  CAS  PubMed  Google Scholar 

  4. Verrees M, Arafah BM, Selman WR (2004) Pituitary tumor apoplexy: characteristics, treatment, and outcomes. Neurosurg Focus 16:E6

    Article  PubMed  Google Scholar 

  5. Turgut M, Ozsunar Y, Başak S et al (2010) Pituitary apoplexy: an overview of 186 cases published during the last century. Acta Neurochir (Wien) 152:749–761. doi:10.1007/s00701-009-0595-8

    Article  Google Scholar 

  6. Nawar RN, AbdelMannan D, Selman WR, Arafah BM (2008) Pituitary tumor apoplexy: a review. J Intensive Care Med 23:75–90. doi:10.1177/0885066607312992

    Article  PubMed  Google Scholar 

  7. Moller-Goede DL, Brandle M, Landau K et al (2011) Pituitary apoplexy: re-evaluation of risk factors for bleeding into pituitary adenomas and impact on outcome. Eur J Endocrinol 164:37–43. doi:10.1530/EJE-10-0651

    Article  CAS  PubMed  Google Scholar 

  8. Ranabir S, Baruah MP (2011) Pituitary apoplexy. Indian J Endocrinol Metab 15(Suppl 3):S188–S196. doi:10.4103/2230-8210.84862

    PubMed  PubMed Central  Google Scholar 

  9. Semple PL, Webb MK, de Villiers JC, Laws ER (2005) Pituitary apoplexy. Neurosurgery 56:65–72 (discussion 72–73)

    PubMed  Google Scholar 

  10. Wildemberg LEA, Neto LV, Niemeyer P et al (2012) Association of dengue hemorrhagic fever with multiple risk factors for pituitary apoplexy. Endocr Pract Off J Am Coll Endocrinol Am Assoc Clin Endocrinol 18:e97–e101. doi:10.4158/EP11341.CR

    Google Scholar 

  11. Carosi G, Malchiodi E, Ferrante E et al (2015) Hypothalamic-pituitary axis in non-functioning pituitary adenomas: focus on the prevalence of isolated central hypoadrenalism. Neuroendocrinology. doi:10.1159/000430815

    PubMed  Google Scholar 

  12. Onesti ST, Wisniewski T, Post KD (1990) Clinical versus subclinical pituitary apoplexy: presentation, surgical management, and outcome in 21 patients. Neurosurgery 26:980–986

    Article  CAS  PubMed  Google Scholar 

  13. Murad-Kejbou S, Eggenberger E (2009) Pituitary apoplexy: evaluation, management, and prognosis. Curr Opin Ophthalmol 20:456–461. doi:10.1097/ICU.0b013e3283319061

    Article  PubMed  Google Scholar 

  14. Endoh M, Wakai S, Iouh S, Nagai M (1994) Massive intraventricular hemorrhage from prolactinoma during bromocriptine therapy: case report. No Shinkei Geka 22:661–664

    CAS  PubMed  Google Scholar 

  15. Sibal L, Ball SG, Connolly V et al (2004) Pituitary apoplexy: a review of clinical presentation, management and outcome in 45 cases. Pituitary 7:157–163. doi:10.1007/s11102-005-1050-3

    Article  PubMed  Google Scholar 

  16. Maïza JC, Bennet A, Thorn-Kany M et al (2004) Pituitary apoplexy and idiopathic thrombocytopenic purpura: a new case and review of the literature. Pituitary 7:189–192. doi:10.1007/s11102-005-1760-6

    Article  PubMed  Google Scholar 

  17. Kelion AD, Shahi M, Bell JA (1997) An unusual neurological problem in a patient admitted for acute myocardial infarction. Postgrad Med J 73:669–670

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  18. Fuchs S, Beeri R, Hasin Y et al (1998) Pituitary apoplexy as a first manifestation of pituitary adenomas following intensive thrombolytic and antithrombotic therapy. Am J Cardiol 81:110–111

    Article  CAS  PubMed  Google Scholar 

  19. Semple PL, Jane JA, Laws ER (2007) Clinical relevance of precipitating factors in pituitary apoplexy. Neurosurgery 61:956–961. doi:10.1227/01.neu.0000303191.57178.2a (discussion 961–962)

    Article  PubMed  Google Scholar 

  20. Audia S, Popitean L, Camus A et al (2006) An unusual complication of anticoagulation therapy in an elderly patient: pituitary apoplexy with remission of acromegaly. J Am Geriatr Soc 54:1798–1800. doi:10.1111/j.1532-5415.2006.00933.x

    Article  PubMed  Google Scholar 

  21. Nagarajan DV, Bird D, Papouchado M (2003) Pituitary apoplexy following anticoagulation for acute coronary syndrome. Heart Br Card Soc 89:10

    Article  CAS  Google Scholar 

  22. Kumar V, Kataria R, Mehta VS (2011) Dengue hemorrhagic fever: a rare cause of pituitary tumor hemorrhage and reversible vision loss. Indian J Ophthalmol 59:311–312. doi:10.4103/0301-4738.82002

    Article  PubMed  PubMed Central  Google Scholar 

  23. Motivala S, Gologorsky Y, Kostandinov J, Post KD (2011) Pituitary disorders during pregnancy. Endocrinol Metab Clin North Am 40:827–836. doi:10.1016/j.ecl.2011.08.007

    Article  CAS  PubMed  Google Scholar 

  24. Schrupp Berg HL, Edlow JA (2007) Post-partum pituitary apoplexy: a case report. Intern Emerg Med 2:311–314. doi:10.1007/s11739-007-0084-0

    Article  CAS  PubMed  Google Scholar 

  25. Mizuno T (2011) Pituitary apoplexy with third cranial nerve palsy after off-pump coronary artery bypass grafting. Interact CardioVasc Thorac Surg 13:240–242. doi:10.1510/icvts.2011.268854

    Article  PubMed  Google Scholar 

  26. Mukhida K, Kolyvas G (2007) Pituitary apoplexy following cardiac surgery. Can J Neurol Sci J Can Sci Neurol 34:390–393

    Article  Google Scholar 

  27. Acar F, Mertol T (2004) Pituitary apoplexy following laparascopic cholocystectomy. Acta Neurochir (Wien) 146:1275–1276. doi:10.1007/s00701-004-0321-5

    Article  CAS  Google Scholar 

  28. Brennan CF, Malone RG, Weaver JA (1956) Pituitary necrosis in diabetes mellitus. Lancet Lond Engl 271:12–16

    Article  CAS  Google Scholar 

  29. Cardoso ER, Peterson EW (1984) Pituitary apoplexy: a review. Neurosurgery 14:363–373

    Article  CAS  PubMed  Google Scholar 

  30. Reid RL, Quigley ME, Yen SS (1985) Pituitary apoplexy. A review. Arch Neurol 42:712–719

    Article  CAS  PubMed  Google Scholar 

  31. Weisberg LA (1977) Pituitary apoplexy. Association of degenerative change in pituitary ademona with radiotherapy and detection by cerebral computed tomography. Am J Med 63:109–115

    Article  CAS  PubMed  Google Scholar 

  32. Biousse V, Newman NJ, Oyesiku NM (2001) Precipitating factors in pituitary apoplexy. J Neurol Neurosurg Psychiatry 71:542–545

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  33. Chapman AJ, Williams G, Hockley AD, London DR (1985) Pituitary apoplexy after combined test of anterior pituitary function. Br Med J Clin Res Ed 291:26

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  34. Arita K, Tominaga A, Sugiyama K et al (2006) Natural course of incidentally found nonfunctioning pituitary adenoma, with special reference to pituitary apoplexy during follow-up examination. J Neurosurg 104:884–891. doi:10.3171/jns.2006.104.6.884

    Article  PubMed  Google Scholar 

  35. Tan TM, Caputo C, Mehta A et al (2007) Pituitary macroadenomas: are combination antiplatelet and anticoagulant therapy contraindicated? A case report. J Med Case Rep 1:74. doi:10.1186/1752-1947-1-74

    Article  PubMed  PubMed Central  Google Scholar 

  36. Dupuy O, Bordier L, Galzin A et al (2010) Uncommon complication of anticoagulant therapy: pituitary hemorrhage. Rev Médecine Interne Fondée Par Société Natl Francaise Médecine Interne 31:e1–e2. doi:10.1016/j.revmed.2010.01.005

    Article  CAS  Google Scholar 

  37. Mou C, Han T, Zhao H et al (2009) Clinical features and immunohistochemical changes of pituitary apoplexy. J Clin Neurosci Off J Neurosurg Soc Australas 16:64–68. doi:10.1016/j.jocn.2008.02.012

    CAS  Google Scholar 

  38. Randeva HS, Schoebel J, Byrne J et al (1999) Classical pituitary apoplexy: clinical features, management and outcome. Clin Endocrinol (Oxf) 51:181–188

    Article  CAS  Google Scholar 

  39. Ayuk J, McGregor EJ, Mitchell RD, Gittoes NJL (2004) Acute management of pituitary apoplexy—surgery or conservative management? Clin Endocrinol (Oxf) 61:747–752. doi:10.1111/j.1365-2265.2004.02162.x

    Article  Google Scholar 

  40. da Motta LA, de Mello PA, de Lacerda CM et al (1999) Pituitary apoplexy. Clinical course, endocrine evaluations and treatment analysis. J Neurosurg Sci 43:25–36

    PubMed  Google Scholar 

  41. McFadzean RM, Doyle D, Rampling R et al (1991) Pituitary apoplexy and its effect on vision. Neurosurgery 29:669–675

    Article  CAS  PubMed  Google Scholar 

  42. Bills DC, Meyer FB, Laws ER et al (1993) A retrospective analysis of pituitary apoplexy. Neurosurgery 33:602–608 (discussion 608–609)

    Article  CAS  PubMed  Google Scholar 

  43. Lubina A, Olchovsky D, Berezin M et al (2005) Management of pituitary apoplexy: clinical experience with 40 patients. Acta Neurochir (Wien) 147:151–157. doi:10.1007/s00701-004-0413-2 (discussion 157)

    Article  CAS  Google Scholar 

  44. Samada K, Shiraishi H, Aoyagi J, Momoi MY (2009) Cerebral hemorrhage associated with sildenafil (Revatio) in an infant. Pediatr Cardiol 30:998–999. doi:10.1007/s00246-009-9460-z

    Article  PubMed  Google Scholar 

  45. Alpsan MH, Bebek N, Ciftci FD et al (2008) Intracerebral hemorrhage associated with sildenafil use: a case report. J Neurol 255:932–933. doi:10.1007/s00415-008-0618-z

    Article  CAS  PubMed  Google Scholar 

  46. Gazzeri R, Neroni M, Galarza M, Esposito S (2008) Intracerebral hemorrhage associated with use of tadalafil (Cialis). Neurology 70:1289–1290. doi:10.1212/01.wnl.0000308939.16685.b6

    Article  PubMed  Google Scholar 

  47. Mehdizadeh M, Hosseini H, Yazdchi T, Farahangiz S (2008) Visual field defect as a presenting sign for hemorrhagic stroke caused by sildenafil. Indian J Ophthalmol 56:159–160

    Article  PubMed  PubMed Central  Google Scholar 

  48. Hellstrom WJG (2006) Visual field defect and intracerebral hemorrhage associated with use of vardenafil (Levitra). Neurology 66:293–294. doi:10.1212/01.wnl.0000204244.93406.5a (author reply 293–294)

    Article  PubMed  Google Scholar 

  49. McGee HT, Egan RA, Clark WM (2005) Visual field defect and intracerebral hemorrhage associated with use of vardenafil (Levitra). Neurology 64:1095–1096. doi:10.1212/01.WNL.0000154468.11834.41

    Article  PubMed  Google Scholar 

  50. Buxton N, Flannery T, Wild D, Bassi S (2001) Sildenafil (Viagra)-induced spontaneous intracerebral haemorrhage. Br J Neurosurg 15:347–349

    Article  CAS  PubMed  Google Scholar 

  51. Monastero R, Pipia C, Camarda LK, Camarda R (2001) Intracerebral haemorrhage associated with sildenafil citrate. J Neurol 248:141–142

    Article  CAS  PubMed  Google Scholar 

  52. Ballard SA, Gingell CJ, Tang K et al (1998) Effects of sildenafil on the relaxation of human corpus cavernosum tissue in vitro and on the activities of cyclic nucleotide phosphodiesterase isozymes. J Urol 159:2164–2171

    Article  CAS  PubMed  Google Scholar 

  53. McHugh J, Cheek DJ (1998) Nitric oxide and regulation of vascular tone: pharmacological and physiological considerations. Am J Crit Care Off Publ Am Assoc Crit-Care Nurses 7:131–140 (quiz 141–142)

    CAS  Google Scholar 

  54. Muthukumar N, Rossette D, Soundaram M et al (2008) Blindness following pituitary apoplexy: timing of surgery and neuro-ophthalmic outcome. J Clin Neurosci Off J Neurosurg Soc Australas 15:873–879. doi:10.1016/j.jocn.2007.08.010

    Google Scholar 

  55. Maccagnan P, Macedo CL, Kayath MJ et al (1995) Conservative management of pituitary apoplexy: a prospective study. J Clin Endocrinol Metab 80:2190–2197. doi:10.1210/jcem.80.7.7608278

    CAS  PubMed  Google Scholar 

  56. Gruber A, Clayton J, Kumar S et al (2006) Pituitary apoplexy: retrospective review of 30 patients–is surgical intervention always necessary? Br J Neurosurg 20:379–385

    Article  CAS  PubMed  Google Scholar 

  57. Rajasekaran S, Vanderpump M, Baldeweg S et al (2011) UK guidelines for the management of pituitary apoplexy. Clin Endocrinol (Oxf) 74:9–20. doi:10.1111/j.1365-2265.2010.03913.x

    Article  Google Scholar 

  58. Takeda N, Fujita K, Katayama S et al (2010) Effect of transsphenoidal surgery on decreased visual acuity caused by pituitary apoplexy. Pituitary 13:154–159. doi:10.1007/s11102-009-0216-9

    Article  PubMed  Google Scholar 

  59. Seyer H, Kömpf D, Fahlbusch R (1992) Optomotor palsies in pituitary apoplexy. Neuro-Ophthalmol 12:217–224. doi:10.3109/01658109209058141

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to M. Minichiello.

Ethics declarations

Conflict of interest

All the authors of this study have no conflict of interest.

Ethical approval

This study has been approved by the Ethical Committee of IRCCS Fondazione Cà Granda Ospedale Maggiore Policlinico. They all have given the permission for the publication of their clinical data.

Informed consent

All the patients included in this study have signed an informed consent form.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Giammattei, L., Mantovani, G., Carrabba, G. et al. Pituitary apoplexy: considerations on a single center experience and review of the literature. J Endocrinol Invest 39, 739–746 (2016). https://doi.org/10.1007/s40618-015-0424-2

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40618-015-0424-2

Keywords

Navigation